SCHEMBL16477274

SCHEMBL16477274

Cc1cc2oc3ccccc3c(=O)c2cc1C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 8/20 0.67
KDM4E B2RXH2 1/20 0.67
ALDH1A1 P00352 1/20 0.67
GLA P06280 1/20 0.67
CYP3A4 P08684 1/20 0.67
MAPT P10636 1/20 0.67
HPGD P15428 1/20 0.67
PGAM1 P18669 1/20 0.67
CASP1 P29466 1/20 0.67
CASP7 P55210 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
HSD17B10 Q99714 1/20 0.67
NPC1 O15118 5/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
RAB9A P51151 4/20 0.58
TTR P02766 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.53
POLB P06746 1/20 0.53
TBK1 Q9UHD2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9836819 0.86 MAOA (0.61) MAOAKDM4EALDH1A1GLACYP3A4
SCHEMBL9837713 0.86 MAOA (0.61) MAOAKDM4EALDH1A1GLACYP3A4
SCHEMBL9218832 0.86 NQO1 (0.48) MAOAKDM4EALDH1A1GLACYP3A4
SCHEMBL21666688 0.84 MAOA (0.78) MAOAKDM4EALDH1A1GLACYP3A4
SCHEMBL172820 0.84 MAOA (0.61) MAOAKDM4EALDH1A1GLACYP3A4
SCHEMBL20329706 0.84 NQO1 (0.47) MAOAKDM4EALDH1A1GLACYP3A4
Xanthone SCHEMBL41161 0.82 MAOA (1.00) MAOAKDM4EALDH1A1GLACYP3A4
Xanthone SCHEMBL29398266 0.82 MAOA (1.00) MAOAKDM4EALDH1A1GLACYP3A4
Xanthone SCHEMBL2354794 0.82 MAOA (1.00) MAOAKDM4EALDH1A1GLACYP3A4
Xanthone SCHEMBL29358061 0.82 MAOA (1.00) MAOAKDM4EALDH1A1GLACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9163002-B2 Methodology for the synthesis of xanthones UNIVERSITY OF SOUTH CAROLINA (US) 2015-10-20 US disclosed
US-9163002-B2 Methodology for the synthesis of xanthones UNIVERSITY OF SOUTH CAROLINA (US) 2015-10-20 US disclosed
US-20140107354-A1 New Methodology for the Synthesis of Xanthones UNIVERSITY OF SOUTH CAROLINA 2014-04-17 US disclosed
US-20140107354-A1 New Methodology for the Synthesis of Xanthones UNIVERSITY OF SOUTH CAROLINA 2014-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140107354-A1 New Methodology for the Synthesis of Xanthones XDH, TYR, NISCH MAOA 68/4885KDM4E 1101/4885ALDH1A1 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.